Skip to main content

Angiogenic/lymphangiogenic factors and adaptation to extreme altitudes during an expedition to Mount Everest

Buy Article:

$51.00 plus tax (Refund Policy)


Abstract Aim: 

To analyse the correlation between production of angiogenic [vascular endothelial growth factor A (VEGF-A) and interleukin 8 (IL-8)] and lymphangiogenic factors (VEGF-C and D) and adaptation to high altitude (>8000 m). Erythropoietin (EPO) served as a positive control. Methods: 

We analysed the percentage of oxygen saturation and the plasmatic contents of VEGF-A, C, D, IL-8 and EPO in seven mountaineers and four Sherpas during an expedition to Mount Everest. Acute mountain sickness was also evaluated using the Lake Louise score. Results: 

Whereas VEGF-A, IL-8, VEGF-C and EPO were transiently up-regulated at 5000 m and decreased at the highest altitudes, VEGF-D remained elevated throughout the ascent. Sherpas had increased basal levels of VEGF-A, C, IL-8 and EPO and up-regulation of all the tested factors when they passed the altitude at which they lived. Conclusion: 

Our data suggest that expression of angiogenic and lymphangiogenic factors is up-regulated directly or indirectly by altitude-dependent hypoxia. Both factors could be involved in a mechanism of adaptation to high altitudes.

Keywords: angiogenesis; extreme altitudes; hypoxia; lymphangiogenesis

Document Type: Research Article


Affiliations: 1:  University of Nice Sophia Antipolis, UMR CNRS 6543, Institute of Signalling, Developmental Biology and Cancer Research, Nice, France 2:  Anaesthesia Department, Saint George Clinic, Nice, France

Publication date: June 1, 2009


Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more